Industry participates in the work of the Alliance through the Industry Forum, the venue for industry members to provide advice and recommendations to the Alliance Scientific Steering Committee and contribute financial support towards the ongoing research initiatives of the Alliance.
Co-Chairs
Marco Salvetti, Director, Neurology Unit, Sant’Andrea University Hospital, Rome; Director, PhD Programme on Clinical and Experimental Neurosciences and Psychiatry, Sapienza University of Rome, (IT)
Florian von Raison, Clinical Development Head Neuroscience, Global Drug Development, Novartis, (FR)
Members
Nektaria Alexandri, MS Global Medical Affairs, EMD Serono/Merck (US)
Bruce Bebo, Executive Vice President of Research, National MS Society (US)
Ivan Bozin, Senior Medical Manager, Biogen, (CH)
Burhan Chaudhry, Senior Clinical Trial Physician, Bristol Myers-Squibb (US)
Licinio Craveiro, Neurologist, Senior Global Medical Director, Genentech Roche, (CH)
Kate Daniels, Director, International Progressive MS Alliance, (US)
Shawna Golden, Vice President, Global Initiatives, International Progressive MS Alliance, (US)
Andrew Goldfine, Senior Clinical Development Director, GlaxoSmithKline (US)
Jerome Hanna, Senior Medical Director, Clinical Development, Biogen, (UK)
Alex Kulla, SVP, Global Head of the Neurology & Immunology, EMD/Serono (US)
Andreas Muehler, Chief Medical Officer, Immunic Therapeutics, (DE)
Chahin Pachai, Director, Medical Imaging, Bristol Myers-Squibb (US)
Daniela Piani Meier, Global Medical Director Neurology & Immunology, EMD Serono/Merck (CH)
Ashish Pradhan, Executive Director Neuroimmunology, Disease Area Lead – Medical Affairs, Genentech, (US)
Laura Rapley, Scientific Lead, Chronic Inflammatory Diseases, GlaxoSmithKline, (UK)
Nikolaos Sfikas, Senior IIS Global Group Head, Novartis, (FR)
Sana Syed, Senior Medical Director, Clinical Lead, Sanofi, (US)
Erik Wallström, Therapeutic Area Head, Neurology, Sanofi, (US)
Paola Zaratin, Director of Scientific Research, AISM — Italian MS Society, (IT)